Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - Other
Ratios

Inmune Bio (INMB) Receivables - Net (2019 - 2025)

Inmune Bio's Receivables - Net history spans 6 years, with the latest figure at $1.7 million for Q3 2025.

  • For Q3 2025, Receivables - Net rose 53.65% year-over-year to $1.7 million; the TTM value through Sep 2025 reached $1.7 million, up 53.65%, while the annual FY2024 figure was $1.2 million, 38.01% down from the prior year.
  • Receivables - Net for Q3 2025 was $1.7 million at Inmune Bio, down from $2.0 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $3.1 million in Q2 2024 and bottomed at $100000.0 in Q1 2021.
  • The 4-year median for Receivables - Net is $1.2 million (2024), against an average of $1.2 million.
  • The largest annual shift saw Receivables - Net tumbled 96.55% in 2021 before it skyrocketed 53.65% in 2025.
  • A 4-year view of Receivables - Net shows it stood at $100000.0 in 2021, then skyrocketed by 1805.0% to $1.9 million in 2023, then plummeted by 38.01% to $1.2 million in 2024, then skyrocketed by 44.28% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for INMB's Receivables - Net are $1.7 million (Q3 2025), $2.0 million (Q2 2025), and $1.3 million (Q1 2025).